Synlogic Is A Biopharmaceutical Company Based In Cambridgemassachusettsfocused On Developing Novel Therapeutics For Serious Diseasesparticularly Rare And Genetic Metabolic Disordersthe Company Specializes In Synthetic Biologycreating Living Medicines Known As Synthetic Bioticsthese Therapeutics Are Designed To Address The Underlying Causes Of Diseases In Innovative Ways The Company S Proprietary Platform Combines Molecular Biologymicrobial Engineeringand Physiology To Develop Drug Candidates For Conditions Such As Phenylketonuriapku Homocystinuriahcu Enteric Hyperoxaluriaand Goutsynlogic Also Explores Treatments For Liver Diseaseinflammatory And Immune Disordersand Cancertheir Development Process Includes Assessing Disease Mechanismsdesigning Biotic Prototypesand Building Synthetic Biotics For Oral Administrationenhancing Patient Experiencesynlogic Collaborates With Pharmaceutical And Biotechnology Companies To Advance Its Drug Development Efforts
